|Description||ORG 30958 is a potent aromatase inhibitor in vivo. ORG 30958 proved to be devoid of antiestrogenic activity which indicates that the absence of cornification of vaginal epithelium in DHEAS-treated Hypex rats is induced by the inhibition of the biosynthesis of estrogens and not by an anti-estrogenic activity.|
|Synonyms||(8S,9S,10S,13S,14S)-10-[(ethyldisulfanyl)methyl]-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione; 19-(ethyldithio)androst-4-ene-3,17-dione; ORG 30958; ORG-30958|
|Storage||Store in a cool and dry place (or refer to the Certificate of Analysis).|
|Boiling Point||532.1±50.0 ℃ at 760 Torr|
LY 56110, a Pyrimidine derivative, is a novel class of nonsteroidal aromatase inhibitor. LY 56110 inhibited ethinamate-induced sleeping time in rats in vivo.
Cgp 45688 is an non-steroidal aromatase inhibitor originated byNovartis. It has anti-tumor effects, but no development for treatment of cancer was reported.
Aminoglutethimide is an anticancer drug that belongs to the family of drugs called nonsteroidal aromatase inhibitors. Aminoglutethimide is used to decrease the ...
This active molecular has a potential antineoplastic activity. As a retinoic acid metabolism blocking agent (RAMBA), liarozole inhibits P450-dependent ATRA-4-hy...
LY 43578 is an aromatase inhibitor.
Cgp 47645 is non-steroidal aromatase inhibitor with anti-tumor and endocrine effects. It is orally active.
YM 511 is a potent aromatase (CYP19) inhibitor (IC50 = 0.4 and 0.12 nM at rat ovary and human placenta cells, respectively) that weakly inhibits the synthesis o...
Formestane is a second generation selective aromatase inhibitor with an IC50 of 80 nM.